Arctic Seaberry vs Arrowhead Root (Sagittaria latifolia)

Current research reports no adverse effects in animal models at tested doses up to 50 mg/kg, though comprehensive human safety data is limited. No specific drug interactions or contraindications have been identified in available studies, but this may reflect insufficient clinical investigation rather than confirmed safety. Pregnant and breastfeeding women should exercise caution due to lack of safety data in these populations. Individuals taking anticoagulant medications should consult healthcare providers, as high vitamin C content may theoretically affect blood clotting parameters.

Arrowhead root is generally recognized as safe when consumed as a whole food and has been eaten for millennia by Indigenous peoples throughout North America and East Asia without reports of significant toxicity. Individuals taking antidiabetic medications (e.g., metformin, sulfonylureas, or insulin) should monitor blood glucose levels when consuming large quantities, as the complex starch and fiber content may additively lower postprandial glycemia. No CYP450 enzyme interactions have been documented for Sagittaria latifolia; however, chlorogenic acid found in related species is a known mild inhibitor of CYP1A2 and CYP3A4 in vitro, which could theoretically affect metabolism of substrates such as caffeine or certain statins at very high intake levels. Persons with known allergies to aquatic plants in the Alismataceae family should exercise caution, and raw tubers should be thoroughly cooked to neutralize potential anti-nutritional factors such as protease inhibitors.